» Authors » Ronald Mitsuyasu

Ronald Mitsuyasu

Explore the profile of Ronald Mitsuyasu including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 51
Citations 1045
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Atkinson T, Mazumdar M, Van Hyfte G, Lee J, Li Y, Lynch K, et al.
JCO Oncol Pract . 2025 Mar; :OP2400830. PMID: 40048673
Purpose: The Anal Cancer/High-grade squamous intraepithelial lesions Outcomes Research (ANCHOR) trial demonstrated that treating precancerous anal HSIL reduces the incidence of anal cancer by 57% in people with HIV. It...
2.
Rajdev L, Jackie Wang C, Joshi H, Lensing S, Lee J, Ramos J, et al.
Cancer . 2023 Nov; 130(6):985-994. PMID: 37962072
Background: Although immunotherapy has emerged as a therapeutic strategy for many cancers, there are limited studies establishing the safety and efficacy in people living with HIV (PLWH) and cancer. Methods:...
3.
Rubinstein P, Moore P, Bimali M, Lee J, Rudek M, Chadburn A, et al.
Lancet Haematol . 2023 Aug; 10(8):e624-e632. PMID: 37532416
Background: Brentuximab vedotin in combination with doxorubicin, vinblastine, and dacarbazine (AVD) is approved in the upfront setting for advanced stage classical Hodgkin lymphoma (cHL). People living with HIV have been...
4.
Atkinson T, Lensing S, Lee J, Chang D, Kim S, Li Y, et al.
Qual Life Res . 2023 Apr; 32(8):2293-2304. PMID: 37020153
Purpose: To determine whether treatment of anal high-grade squamous intraepithelial lesions (HSIL), vs active monitoring, is effective in reducing incidence of anal cancer in persons living with HIV, the US...
5.
Etemad B, Sun X, Li Y, Melberg M, Moisi D, Gottlieb R, et al.
Proc Natl Acad Sci U S A . 2023 Mar; 120(11):e2218960120. PMID: 36877848
HIV post-treatment controllers (PTCs) are rare individuals who maintain low levels of viremia after stopping antiretroviral therapy (ART). Understanding the mechanisms of HIV post-treatment control will inform development of strategies...
6.
Thomas N, Dreval K, Gerhard D, Hilton L, Abramson J, Ambinder R, et al.
Blood . 2022 Oct; 141(8):904-916. PMID: 36201743
Burkitt lymphoma (BL) accounts for most pediatric non-Hodgkin lymphomas, being less common but significantly more lethal when diagnosed in adults. Much of the knowledge of the genetics of BL thus...
7.
Martinez L, Lensing S, Chang D, Magpantay L, Mitsuyasu R, Ambinder R, et al.
Sci Rep . 2022 Jun; 12(1):9185. PMID: 35655072
Emerging evidence shows that tumor cells secrete extracellular vesicles (EVs) that carry bioactive cell surface markers, such as programmed death-ligand 1 (PD-L1), which can modulate immune responses and inhibit anti-tumor...
8.
Reid E, Shimabukuro K, Moore P, Ambinder R, Bui J, Han S, et al.
Clin Cancer Res . 2022 Mar; 28(12):2646-2656. PMID: 35247913
Purpose: Kaposi sarcoma (KS), an endothelial cell tumor associated with KS herpesvirus (KSHV), remains among the most common malignancies occurring with HIV infection (HIV-KS). As an oral anti-inflammatory, antiangiogenic, and...
9.
Martinez L, Lensing S, Chang D, Magpantay L, Mitsuyasu R, Ambinder R, et al.
Clin Cancer Res . 2021 Jun; 27(16):4642-4651. PMID: 34131000
Purpose: AIDS-related non-Hodgkin lymphoma (ARL) is the most common cancer in HIV-infected individuals in the United States and other countries in which HIV-positive persons have access to effective combination antiretroviral...
10.
Ramos J, Sparano J, Chadburn A, Reid E, Ambinder R, Siegel E, et al.
Blood . 2020 May; 136(11):1284-1297. PMID: 32430507
EPOCH (etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin) is a preferred regimen for HIV-non-Hodgkin lymphomas (HIV-NHLs), which are frequently Epstein-Barr virus (EBV) positive or human herpesvirus type-8 (HHV-8) positive. The histone...